SWISS-MODEL web services will be unavailable between 08:00 CET and 10:00 CET, Thursday, 14th November.
Jobs started before this time will not be affected.

P17931 (LEG3_HUMAN) Homo sapiens (Human)

Galectin-3 UniProtKBInterProSTRINGInteractive Modelling

250 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: A0A024R693

Available Structures

118 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of a crystallized variant of h-Gal3: Gal-3[NTS/VII-IX] Heteromer
101-250
100BGC; 10×SO4;
Crystal structure of the recombinant Fab fragment derived from the hybridoma M3/38 in complex with … Heteromer
57-65
100
Crystal structure of human Galectin-3 in complex with small molecule inhibitorhomo-2-mer113-250
100CL;SXP;PZE;
Crystal structure of Human galectin-3 CRD in complex with LNTmonomer112-250
100BGC;CL;
Crystal structure of Human galectin-3 CRD in complex with LNnTmonomer112-250
100GLC;CL;
Crystal structure of human galectin-3 CRD in complex with selenodigalactosidemonomer112-250
1004IZ;CL;
Crystal structure of Human galectin-3 CRD in complex with Methyl 3-O-[1-(b-D-galactopyranosyl)-1,2,…monomer112-250
100P8J;CL;
Crystal structure of Human galectin-3 CRD in complex with Methyl 3-O-(1-{3-O-[1-(b-D-galactopyranos…monomer112-250
100CL;P8G;
Crystal structure of human galectin-3 CRD in complex with diselenodigalactosidemonomer112-250
1004IW;MG;CL;
Crystal structure of Human Galectin-3 CRD in complex with Lactose at 0.86 angstrom resolutionmonomer113-250
100BGC;
Galectin-3C in complex with para-fluoroaryltriazole galactopyranosyl 1-thio-D-glucopyranoside deriv…monomer113-250
100KOQ;CL;
Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative 1monomer113-250
100H5Z;
Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative 5monomer113-250
100J4N;CL;
Structure of human Galectin-3 CRD in complex with monosaccharide inhibitormonomer113-250
100D9J;
Galectin-3C in complex with fluoroaryl triazole monothiogalactoside derivative 2monomer113-250
100J5Q;
Galectin-3 carbohydrate recognition domain in complex with lactitolmonomer113-250
100SOR;
Galectin-3C in complex with meta-fluoroaryltriazole galactopyranosyl 1-thio-D-glucopyranoside deriv…monomer113-250
100KOW;CL;
Galectin-3C in complex with ortho-fluoroaryltriazole galactopyranosyl 1-thio-D-glucopyranoside deri…monomer113-250
100KP5;
Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:4(Bromine)monomer113-250
100KOE;SCN;
Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:3(Chlorine)monomer113-250
100KOZ;CL;
Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative 6monomer113-250
100HRK;CL;
Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative 4monomer113-250
100PEG;J4E;CL;
Human Galectin-3 CRD in complex with novel tetrahydropyran-based thiodisaccharide mimic inhibitormonomer113-250
100MG;CL;H5O;
Galectin-3C in complex with a triazolesulfone derivativemonomer113-250
100SCN;YJF;MG;
Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative 3monomer113-250
100PGE;J3Q;CL;
Galectin-3C in complex with a triazolesulfane derivativemonomer113-250
100SCN;YJO;MG;
Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:1(Hydrogen)monomer113-250
100KP8;SCN;
Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:2(Fluorine)monomer113-250
100KPB;SCN;
Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative-8monomer113-250
100J62;CL;
Galectin-3c in complex with Bisamido-thiogalactoside derivative 4monomer113-250
1006E1;
Galectin-3C in complex with a triazolesulfane derivativemonomer113-250
100Y58;SCN;
Galectin-3C in complex with dithiogalactoside derivativemonomer113-250
1009SK;
Galectin-3C in complex with fluoroaryltriazole monothiogalactoside derivative-7monomer113-250
100PEG;J5W;
Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative 5monomer113-250
100H5H;
Galectin-3 carbohydrate recognition domain in complex with thioditalosidemonomer113-250
100TWJ;CL;
Galectin-3C in complex with a pair of enantiomeric ligands: S enantiomermonomer113-250
100J1E;
Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative 2monomer113-250
100H5T;
Galectin-3C in complex with substituted fluoroaryltriazole monothiogalactoside derivative 1monomer113-250
100J5E;CL;
Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.5, PEG6000)monomer113-250
100BGC;
Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.0, PEG4000)monomer113-250
100BGC;
Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative-3monomer113-250
100H5N;
Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.0, PEG 6000)monomer113-250
100BGC;
Galectin-3C in complex with substituted polyfluoroaryl monothiogalactoside derivative-4monomer113-250
100H5Q;
Crystal structure of human Galectin-3 in complex with small molecule inhibitormonomer113-250
100CL;QB2;NA;
Galectin-3 CRD binds to GalA dimermonomer113-250
100GTR;
Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.9, PEG6000)monomer113-250
100BGC;
Crystal structure of Human galectin-3 CRD in complex with Lactulosemonomer113-250
100FRU;CL;
Room temperature data of Galectin-3C in complex with a pair of enantiomeric ligands: R enantiomermonomer113-250
100J0T;
Structure od the carbohydrate reconition domain of Gal3 in comples with SAF-2-010monomer113-250
100SQR;
Galectin-3C in complex with a pair of enantiomeric ligands: R enantiomermonomer113-250
100J0T;
Galectin-3C in complex with trifluoroaryltriazole monothiogalactoside derivative:5(Iodine)monomer113-250
100KON;PEG;CL;
Crystal structure of human galectin-3 carbohydrate-recognition domain at 1.35 angstrom resolutionmonomer113-250
100BGC;CL;GOL;
Crystal structure of human galectin-3 carbohydrate-recognition domain with lactose bound, at 1.35 a…monomer113-250
100BGC;GLC;GOL;CL;
High Resolution X-Ray Structure of Human Galectin-3 in complex with LacNAcmonomer113-250
100NAG;CL;BR;
Galectin-3 carbohydrate recognition domain in complex with thiodigalactosidemonomer113-250
100YIO;CL;
Galectin-3 CRD binds to GalA trimermonomer113-250
100GTR;
Crystal Structure of the human galectin-3 CRD in complex with a 3'-derivative of N-Acetyllactosaminemonomer113-250
100NAG;BEK;CL;
Crystal Structure of Human Galectin-3 CRD in Complex with TAZTDGmonomer113-250
100TGZ;
Structure of Galectin-3 CRD in complex with compound 3monomer113-250
100TVD;
Structure of Galectin-3 CRD in complex with compound 4monomer113-250
1008VT;
Structure of Galectin-3 CRD in complex with compound 1monomer113-250
100TVD;
Structure of Galectin-3 CRD in complex with glycerolmonomer113-250
100GOL;
Room temperature data of Galectin-3C in complex with a pair of enantiomeric ligands: S enantiomermonomer113-250
100J1E;
Crystal structure of human Galectin-3 in complex with methyl 2-O-acetyl-3-O-toluoyl-beta-D-talopyra…monomer113-250
100CL;MQT;
Crystal structure of Human galectin-3 CRD in complex with a-GM3monomer113-250
100BGC;CL;
Structure of galectin-3C in complex with lactose determined by serial crystallography using an Xtal…monomer113-250
100BGC;CL;
Structure of galectin-3C in complex with lactose determined by serial crystallography using a silic…monomer113-250
100BGC;
Galectin-3 in complex with Methyl 2,6-anhydro-3-deoxy-3-S-(b-D-galactopyranosyl)-3-thio-D-glycero-L…monomer113-250
100CL;YIO;VPH;
Galectin-3 in complex with 2,6-anhydro-3-deoxy-3-S-(beta-D-galactopyranosyl)-3-thio-D-glycero-L-alt…monomer113-250
100YIO;VPL;MG;
Galectin-3 in complex with 2,6-Anhydro-5-S-(beta-D-galactopyranosyl)-5-thio-D-altritolmonomer113-250
100MG;AH2;YIO;
Galectin-3 in complex with 2,6-anhydro-3-deoxy-3-S-(beta-D-galactopyranosyl)-3-thio-D-glycero-D-gal…monomer113-250
100VPQ;YIO;MG;
Galectin-3 carbohydrate recognition domain in complex with thiodigalactoside at 1.8 resolutionmonomer113-250
100GAL;CL;GOL;
Structure of Galectin-3 CRD in complex with compound 2monomer113-250
1008VW;
Crystal structure of Human galectin-3 CRD in complex with lactose (pH 7.5, PEG6000)monomer113-250
100BGC;
Crystal Structure of Human Galectin-3 CRD in Complex with TD139monomer113-250
100TD2;
Crystal Structure of Human Galectin-3 CRD in Complex with Type 1 N-acetyllactosaminemonomer113-250
100NAG;
Crystal structure of human galectin-3 carbohydrate-recognising domain at 2.45 angstrom resolutionmonomer113-250
100BGC;
Neutron crystal structure of perdeuterated galectin-3C in complex with lactosemonomer113-250
100BGC;
Neutron crystal structure of perdeuterated galectin-3C in complex with glycerolmonomer113-250
100GOL;
Neutron crystal structure of perdeuterated galectin-3C in the ligand-free formmonomer113-250
100
Crystal structure of Human Galectin-3 CRD with glycerol bound at 0.90 angstrom resolutionmonomer114-250
100GOL;
Galectin-3c in complex with Bisamido-thiogalactoside derivate 3monomer114-250
100A6J;
Human galectin-3c in complex with a galactose derivativemonomer114-250
100GOL;SCN;CL;JU0;MOH;
Co-crystallization of human galectin-3 CRD complex with Methyl 2-O-(2-nitro-4-chloro)-benzoyl-3-O-t…monomer114-250
100CL;59O;
Galectin-3c in complex with Bisamido-thiogalactoside derivate 1monomer114-250
100GMK;
Crystal structure of Apo Human Galectin-3 CRD at 1.08 angstrom resolution, at cryogenic temperaturemonomer114-250
100
Human Galectin-3 in complex with a TF tumor-associated antigen mimeticmonomer114-250
100EGZ;CL;
Human galectin-3c in complex with a galactose derivativemonomer114-250
100BKK;CL;SCN;
Galectin-3c in complex with thiogalactoside derivatemonomer114-250
1009Q5;
Human galectin-3 in complex with a benzamido-N-acetyllactoseamine inhibitormonomer114-250
100NAG;CL;UNU;
Galectin-3c in complex with Bisamido-thiogalactoside derivate 2monomer114-250
10070B;
Co-crystallization of human galectin-3 CRD complex with Methyl 2-O-(2-nitro-4-fluoro)-benzoyl-3-O-t…monomer114-250
100CL;5A4;
Human Galectin-3 in complex with LacdiNAcmonomer114-250
100NDG;GOL;CL;
Crystal structure of Apo Human Galectin-3 CRD at 1.25 angstrom resolution, at room temperaturemonomer114-250
100
Crystal structure of human galectin-3 CRD in complex with Methyl 2-O-(2-nitro-4-chloro)-benzoyl-3-O…monomer114-250
100CL;59O;
Human galectin-3c in complex with a galactose derivativemonomer114-250
100SCN;CL;N6B;
Crystal structure of galectin-3 CRD in complex with galactopentaosemonomer114-250
100GAL;
Crystal structure of human galectin-3 CRD in complex with Methyl 2-O-(3-nitro-benzoyl)-3-toluoyl-b-…monomer114-250
100CL;5EI;
Crystal structure of human galectin-3 CRD in complex with Methyl 2-O-(2-nitro-4-fluoro)-benzoyl-3-O…monomer114-250
100CL;5A4;
Crystal structure of human galectin-3 CRD in complex with Methyl 2-O-(2-nitro-4-trifluoromethyl-ben…monomer114-250
100CL;5BI;
Crystal structure of Human galectin-3 CRD in complex with 3-fluophenyl-1,2,3-triazolyl thiodigalact…monomer114-250
100CL;TD2;
Human galectin-3c in complex with a galactose derivativemonomer114-250
100CL;N62;
Human galectin-3c in complex with a galactose derivativemonomer114-250
100SCN;BKH;
Crystal structure of Human galectin-3 CRD in complex with 4-fluophenyl-1,2,3-triazolyl thiodigalact…monomer114-250
100CL;5KS;
Crystal structure of Human galectin-3 CRD in complex with methyl 2-O-acetyl-3-O-(2H-chromene-3-yl-m…monomer114-250
100CL;5SY;
Crystal structure of human galectin-3 carbohydrate recognition domain in complex with methyl 3-deox…monomer114-250
100CL;DQT;
Crystal structure of human galectin-3 CRD in complex with Methyl 2-O-(2-nitrobenzoyl)-3-O-(4-methyl…monomer114-250
100CL;57I;
Crystal structure of Human galectin-3 CRD K176L mutant in complex with a-GM3monomer114-250
99.27BGC;CL;
Crystal structure of Human galectin-3 CRD in complex with thienyl-1,2,3-triazolyl thiodigalactoside…monomer114-250
100CL;5KT;
Crystal structure of Human galectin-3 CRD K176L mutant in complex with LNnTmonomer114-250
99.27BGC;CL;
Crystal structure of the CRD-SATmonomer114-250
98.54GLC;SO4;
Crystal structure of Human galectin-3 CRD K176L mutant in complex with LNTmonomer114-250
99.27BGC;CL;
Structure of human Galectin-3 CRD in complex with TD-139 belonging to P31 space group.monomer114-250
100CL;TD2;
X-RAY CRYSTAL STRUCTURE OF THE HUMAN GALECTIN-3 CARBOHYDRATE RECOGNITION DOMAIN (CRD) AT 2.1 ANGSTR…monomer114-250
100NAG;
Crystal structure of galectin-3 CRD domian complexed with GM1 pentasaccharidemonomer117-250
100GOL;SO4;BME;
Crystal structure of galectin-3 CRD domian complexed with TFNmonomer117-250
100A2G;NPO;SO4;
Crystal structure of galectin-3 CRD domian complexed with lactosemonomer117-250
100BGC;SO4;
Crystal structure of galectin-3 CRD domian complexed with Thomsen-Friedenreich antigenmonomer117-250
100A2G;THR;SO4;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6fof.1.Ahomo-4-mer0.78101-250
BGC;100.00